FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yan Huang

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Physiology

Mutagenesis, Site-Directed

Co-author Network

Publications

TOP 3
Robert Anderson; Yan Huang; Joanne M Langley
Prospects for defined epitope vaccines for respiratory syncytial virus.
Yan Huang; Sonya L Cyr; David S Burt; Robert Anderson
Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
Anita C Benoit; Yan Huang; Santi Maneewatchararangsri; Pramuan Tapchaisri; Robert Anderson
Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yan Huang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Robert Anderson; Yan Huang; Joanne M Langley
Prospects for defined epitope vaccines for respiratory syncytial virus.
Future microbiology 2010;5(4):585-602.
2009: Yan Huang; Sonya L Cyr; David S Burt; Robert Anderson
Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2009;44(4):287-91.
2007: Anita C Benoit; Yan Huang; Santi Maneewatchararangsri; Pramuan Tapchaisri; Robert Anderson
Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease.
Vaccine 2007;25(45):7754-62.
2006: A Benoit; Yan Huang; J Proctor; Geoffrey Rowden; Robert Anderson
Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV).
Clinical and experimental immunology 2006;145(1):147-54.
2005: Yan Huang; Robert Anderson
Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus.
Journal of virology 2005;79(7):4527-32.
2003: Yan Huang; Robert Anderson
A single amino acid substitution in a recombinant G protein vaccine drastically curtails protective immunity against respiratory syncytial virus (RSV).
Vaccine 2003;21(19-20):2500-5.
2003: Cheng-Hsien Chang; Yan Huang; Robert Anderson
Activation of vascular endothelial cells by IL-1alpha released by epithelial cells infected with respiratory syncytial virus.
Cellular immunology 2003;221(1):37-41.
2002: Yan Huang; Robert Anderson
Enhanced immune protection by a liposome-encapsulated recombinant respiratory syncytial virus (RSV) vaccine using immunogenic lipids from Deinococcus radiodurans.
Vaccine 2002;20(11-12):1586-92.
2002: Cheng-Hsien Chang; Yan Huang; Andrew C Issekutz; May Griffith; Kuei-Hsiang Lin; Robert Anderson
Interleukin-1alpha released from epithelial cells after adenovirus type 37 infection activates intercellular adhesion molecule 1 expression on human vascular endothelial cells.
Journal of virology 2002;76(1):427-31.
2000: D Mader; Yan Huang; C Wang; R Fraser; Andrew C Issekutz; Andrew W Stadnyk; Robert Anderson
Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge.
Vaccine 2000;18(11-12):1110-7.